MedTrace Logo

Weaning Protocol for High Flow Nasal Cannula Oxygen Therapy

NCT03845244 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-04-18

No results posted yet for this study

Summary

High flow nasal cannula oxygen therapy has been widely used in critically ill patients. Despite effectiveness of high flow nasal cannula as a treatment, optimal methods to withdrawal high flow nasal cannula after recovery from preexisting conditions has not been investigated to date. In this study, we will evaluate the efficacy and safety of three different weaning methods in patients with high flow nasal cannula oxygen therapy.

Conditions

  • High Flow Nasal Cannula
  • Respiratory Insufficiency

Interventions

DEVICE

Flow reduction first

-10L/min q 1hr

DEVICE

FiO2 reduction first

\- 0.1 q 1hr

DEVICE

Simultaneous (flow and FiO2) reduction

-10L/min and -0.1 q 1hr

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Eun Sun Kim, MD · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-24
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03845244 on ClinicalTrials.gov